Use this URL to cite or link to this record in EThOS: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.769453
Title: miR-542 : a novel regulator for muscle mass and function
Author: Farre Garros, Roser
ISNI:       0000 0004 7657 748X
Awarding Body: Imperial College London
Current Institution: Imperial College London
Date of Award: 2018
Availability of Full Text:
Access from EThOS:
Access from Institution:
Abstract:
Loss of skeletal muscle mass and function is a common co-morbidity of a number of chronic diseases including chronic obstructive pulmonary disease (COPD) and a range of critical illnesses as well as in ageing, affecting the quality of life of these individuals. However, the mechanisms by which this occurs have not been completely elucidated. Previous studies in the group identified changed in the levels of several microRNAs in the quadriceps of COPD patients. We focused on the microRNAs that showed the largest and most significant increased expression between patients and controls. One of the elevated microRNAs was miR-542-3p, which was chosen after performing a bioinformatics analysis and saw interesting predicted targets in the muscle wasting context. MiR-542-3p was also found to be elevated in the quadriceps muscle of sarcopenic patients. In this thesis, we aimed to determine if miR-542-5p was also elevated in those two cohorts and if a similar pattern for miR-542-3p/-5p was seen in critical illness such as patients with intensive care unit acquired weakness (ICUAW). We also aimed to identify the molecular pathways by which these miRNAs contributed to muscle impairment or dysfunction. miR-542-3p/5p levels were found elevated in COPD and sarcopenic patients but more markedly elevated in patients with ICUAW. In vitro, miR-542-3p decreased the expression of mitochondrial (MRPS10) and cytoplasmic (RPS23) ribosomal proteins and reduced 12S and 18S ribosomal RNA (rRNA) suggesting mitochondrial and cytoplasmic ribosomal stress. miR-542-3p/-5p promoted the nuclear accumulation of phospho SMAD2/3 and suppressed expression of SMURF1, SMAD7 and PPP2CA which are inhibitors of the system, indicative of increased TGF-β signalling. In vivo, miR-542 over expression caused muscle wasting in the targeted muscle, decreased mitochondrial function, 12S rRNA and 18S rRNA levels and SMAD7 expression, consistent with the effects of the miRNA in vitro. In patients with ICUAW similar results were observed, the expression of 12S and 18S rRNA and SMURF1, SMAD7 and PPP2CA were reduced, suggesting mitochondrial and cytoplasmic ribosomal stress and increased TGF-β signalling.
Supervisor: Kemp, Paul ; Natanek, Amanda Sponsor: National Institute for Health Research
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.769453  DOI:
Share: